Hallucinations are a persistent problem in healthcare. Here's how GSK is using test-time compute scaling to improve its gen AI systems.

Cerebras Systems has teamed with Mayo Clinic to create an AI genomic foundation model that predicts the best medical treatments.

The rise of Nvidia has spurred renewed investor interest in AI chip startups. One of them, Blaize, founded by former Intel ...

As one year ends and another begins, this is often the time when people change jobs and companies change strategies. So it is ...

While Nvidia and the European Union have expressed their displeasure with the latest salvo of AI export restrictions from the ...

Perhaps no document has ever had a more appropriate title than the “Interim Final Rule on Artificial Intelligence Diffusion” ...

The JP Morgan Healthcare Conference will show us many examples of how AI is affecting Healthcare. Cerebras and Nvidia are ...

Cerebras IPO is highly anticipated in 2025. Their stock could set the tone for the year on whether the AI industry will ...

Find out how AI accelerators revolutionize computing by overcoming the challenges of classic von Neumann architecture.

Currently, we estimate that Nvidia accounts for roughly 25% of the entire data center segment. Our view is that Nvidia will ...

updated The Biden administration is reportedly weighing new limits in the ongoing US-China trade war, which would ban high-end AI accelerators to adversary nations and impose restrictions on AI models ...

Although 2024 was an exceptionally lackluster year for new public offerings, the IPO market could gain momentum in 2025. In ...